We are analyzing https://link.springer.com/article/10.1186/s12967-018-1492-9.

Title:
MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus | Journal of Translational Medicine
Description:
Background MicroRNAs (miRNAs) play an important role in cancer biology. Neoadjuvant radiochemotherapy followed by surgery is a standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). However, a subset of patients do not respond. We evaluated whether miRNA profiles can predict resistance to radiochemotherapy. Methods Formalin-fixed, paraffin-embedded pretherapeutic biopsies of patients treated by radiochemotherapy followed by esophagectomy were analyzed. The response was determined by histopathological tumor regression grading. miRNA profiling was performed by microarray analysis (Agilent platform) in 16 non-responders and 15 responders. Differentially expressed miRNAs were confirmed by real-time quantitative PCR (qRT-PCR) in an expanded cohort of 53 cases. Results The miRNA profiles within and between non-responders and responders were highly similar (r = 0.96, 0.94 and 0.95). However, 12 miRNAs were differentially expressed (> twofold; p ≤ 0.025): non-responders showed upregulation of hsa-miR-1323, hsa-miR-3678-3p, hsv2-miR-H7-3p, hsa-miR-194*, hsa-miR-3152, kshv-miR-K12-4-3p, hsa-miR-665 and hsa-miR-3659 and downregulation of hsa-miR-126*, hsa-miR-484, hsa-miR-330-3p and hsa-miR-3653. qRT-PCR analysis confirmed the microarray findings for hsa-miR-194* and hsa-miR-665 (p < 0.001 each) with AUC values of 0.811 (95% CI 0.694–0.927) and 0.817 (95% CI 0.704–0.930), respectively, in ROC analysis. Conclusions Our results indicate that miRNAs are involved in the therapeutic response in ESCC and suggest that miRNA profiles could facilitate pretherapeutic patient selection.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Books & Literature

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

analysis, article, pubmed, mirnas, mirna, google, scholar, expression, cancer, esophageal, patients, microarray, cas, hsamir, data, neoadjuvant, cell, response, tumor, nonresponders, results, responders, squamous, samples, carcinoma, rna, microrna, radiochemotherapy, tissue, surgery, regression, table, levels, profiling, micrornas, treatment, escc, differentially, expressed, survival, studies, study, central, research, profiles, agilent, potential, pcr, therapy, ffpe,

Topics {✒️}

single real-time rt-pcr formalin-fixed paraffin-embedded tissues formalin-fixed paraffin-embedded samples cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil real-time rt-pcr real-time quantitative pcr real-time pcr reactions paraffin-embedded pretherapeutic biopsies squamous cell carcinoma article download pdf rupert langer article slotta-huspenina enhances chemotherapy-induced cytotoxicity microrna-133b predicts chemosensitivity prospective phase-ii trial squamous cell carcinomas real-time pcr external-beam radiotherapy radiation paraffin-embedded tissues hsv2-mir-h7-3p kshv-mir-k12-4-3p single qrt-pcr analysis solely mirna-based study reproducible tissue-generated data cyanine-3-labeled mirna samples mir-483-5p-binding site tissue-based expression analysis upregulated mir-376a-3p quantitative rt-pcr cut-offs defined low mirna-expressing tumors microarray-based mirna analysis cyanine-3-labeled mirna sample mirna primer sets translational medicine aims pubmed literature research full access mol cell biochem methods formalin-fixed posttreatment resection specimens downregulated mir-193b-3p qrt-pcr analysis confirmed privacy choices/manage cookies including small rnas tumor cell content small sample size mirna expression profiles multivariate analysis encompassing technische universität münchen pathologic tumor stage

Schema {🗺️}

WebPage:
      mainEntity:
         headline:MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
         description:MicroRNAs (miRNAs) play an important role in cancer biology. Neoadjuvant radiochemotherapy followed by surgery is a standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). However, a subset of patients do not respond. We evaluated whether miRNA profiles can predict resistance to radiochemotherapy. Formalin-fixed, paraffin-embedded pretherapeutic biopsies of patients treated by radiochemotherapy followed by esophagectomy were analyzed. The response was determined by histopathological tumor regression grading. miRNA profiling was performed by microarray analysis (Agilent platform) in 16 non-responders and 15 responders. Differentially expressed miRNAs were confirmed by real-time quantitative PCR (qRT-PCR) in an expanded cohort of 53 cases. The miRNA profiles within and between non-responders and responders were highly similar (r = 0.96, 0.94 and 0.95). However, 12 miRNAs were differentially expressed (> twofold; p ≤ 0.025): non-responders showed upregulation of hsa-miR-1323, hsa-miR-3678-3p, hsv2-miR-H7-3p, hsa-miR-194*, hsa-miR-3152, kshv-miR-K12-4-3p, hsa-miR-665 and hsa-miR-3659 and downregulation of hsa-miR-126*, hsa-miR-484, hsa-miR-330-3p and hsa-miR-3653. qRT-PCR analysis confirmed the microarray findings for hsa-miR-194* and hsa-miR-665 (p < 0.001 each) with AUC values of 0.811 (95% CI 0.694–0.927) and 0.817 (95% CI 0.704–0.930), respectively, in ROC analysis. Our results indicate that miRNAs are involved in the therapeutic response in ESCC and suggest that miRNA profiles could facilitate pretherapeutic patient selection.
         datePublished:2018-04-25T00:00:00Z
         dateModified:2018-05-16T00:00:00Z
         pageStart:1
         pageEnd:9
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12967-018-1492-9
         keywords:
            Esophagus
            Squamous cell carcinoma
            miRNA
            Neoadjuvant therapy
            Response
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-018-1492-9/MediaObjects/12967_2018_1492_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-018-1492-9/MediaObjects/12967_2018_1492_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-018-1492-9/MediaObjects/12967_2018_1492_Fig3_HTML.gif
         isPartOf:
            name:Journal of Translational Medicine
            issn:
               1479-5876
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Julia Slotta-Huspenina
               affiliation:
                     name:Technische Universität München
                     address:
                        name:Institute of Pathology, Technische Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Enken Drecoll
               affiliation:
                     name:Technische Universität München
                     address:
                        name:Institute of Pathology, Technische Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marcus Feith
               affiliation:
                     name:Klinikum Rechts der Isar, Technische Universität München
                     address:
                        name:Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daniel Habermehl
               affiliation:
                     name:Klinikum Rechts der Isar, Technische Universität München
                     address:
                        name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephanie Combs
               affiliation:
                     name:Klinikum Rechts der Isar, Technische Universität München
                     address:
                        name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wilko Weichert
               affiliation:
                     name:Technische Universität München
                     address:
                        name:Institute of Pathology, Technische Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marcus Bettstetter
               affiliation:
                     name:Teilgemeinschaftspraxis Molekularpathologie Südbayern
                     address:
                        name:Teilgemeinschaftspraxis Molekularpathologie Südbayern, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karen Becker
               affiliation:
                     name:Technische Universität München
                     address:
                        name:Institute of Pathology, Technische Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rupert Langer
               url:http://orcid.org/0000-0001-9491-3609
               affiliation:
                     name:University of Bern
                     address:
                        name:Institute of Pathology, University of Bern, Bern, Switzerland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
      description:MicroRNAs (miRNAs) play an important role in cancer biology. Neoadjuvant radiochemotherapy followed by surgery is a standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). However, a subset of patients do not respond. We evaluated whether miRNA profiles can predict resistance to radiochemotherapy. Formalin-fixed, paraffin-embedded pretherapeutic biopsies of patients treated by radiochemotherapy followed by esophagectomy were analyzed. The response was determined by histopathological tumor regression grading. miRNA profiling was performed by microarray analysis (Agilent platform) in 16 non-responders and 15 responders. Differentially expressed miRNAs were confirmed by real-time quantitative PCR (qRT-PCR) in an expanded cohort of 53 cases. The miRNA profiles within and between non-responders and responders were highly similar (r = 0.96, 0.94 and 0.95). However, 12 miRNAs were differentially expressed (> twofold; p ≤ 0.025): non-responders showed upregulation of hsa-miR-1323, hsa-miR-3678-3p, hsv2-miR-H7-3p, hsa-miR-194*, hsa-miR-3152, kshv-miR-K12-4-3p, hsa-miR-665 and hsa-miR-3659 and downregulation of hsa-miR-126*, hsa-miR-484, hsa-miR-330-3p and hsa-miR-3653. qRT-PCR analysis confirmed the microarray findings for hsa-miR-194* and hsa-miR-665 (p < 0.001 each) with AUC values of 0.811 (95% CI 0.694–0.927) and 0.817 (95% CI 0.704–0.930), respectively, in ROC analysis. Our results indicate that miRNAs are involved in the therapeutic response in ESCC and suggest that miRNA profiles could facilitate pretherapeutic patient selection.
      datePublished:2018-04-25T00:00:00Z
      dateModified:2018-05-16T00:00:00Z
      pageStart:1
      pageEnd:9
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12967-018-1492-9
      keywords:
         Esophagus
         Squamous cell carcinoma
         miRNA
         Neoadjuvant therapy
         Response
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-018-1492-9/MediaObjects/12967_2018_1492_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-018-1492-9/MediaObjects/12967_2018_1492_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-018-1492-9/MediaObjects/12967_2018_1492_Fig3_HTML.gif
      isPartOf:
         name:Journal of Translational Medicine
         issn:
            1479-5876
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Julia Slotta-Huspenina
            affiliation:
                  name:Technische Universität München
                  address:
                     name:Institute of Pathology, Technische Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Enken Drecoll
            affiliation:
                  name:Technische Universität München
                  address:
                     name:Institute of Pathology, Technische Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marcus Feith
            affiliation:
                  name:Klinikum Rechts der Isar, Technische Universität München
                  address:
                     name:Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daniel Habermehl
            affiliation:
                  name:Klinikum Rechts der Isar, Technische Universität München
                  address:
                     name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephanie Combs
            affiliation:
                  name:Klinikum Rechts der Isar, Technische Universität München
                  address:
                     name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wilko Weichert
            affiliation:
                  name:Technische Universität München
                  address:
                     name:Institute of Pathology, Technische Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marcus Bettstetter
            affiliation:
                  name:Teilgemeinschaftspraxis Molekularpathologie Südbayern
                  address:
                     name:Teilgemeinschaftspraxis Molekularpathologie Südbayern, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karen Becker
            affiliation:
                  name:Technische Universität München
                  address:
                     name:Institute of Pathology, Technische Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rupert Langer
            url:http://orcid.org/0000-0001-9491-3609
            affiliation:
                  name:University of Bern
                  address:
                     name:Institute of Pathology, University of Bern, Bern, Switzerland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Translational Medicine
      issn:
         1479-5876
      volumeNumber:16
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Technische Universität München
      address:
         name:Institute of Pathology, Technische Universität München, Munich, Germany
         type:PostalAddress
      name:Technische Universität München
      address:
         name:Institute of Pathology, Technische Universität München, Munich, Germany
         type:PostalAddress
      name:Klinikum Rechts der Isar, Technische Universität München
      address:
         name:Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
         type:PostalAddress
      name:Klinikum Rechts der Isar, Technische Universität München
      address:
         name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
         type:PostalAddress
      name:Klinikum Rechts der Isar, Technische Universität München
      address:
         name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
         type:PostalAddress
      name:Technische Universität München
      address:
         name:Institute of Pathology, Technische Universität München, Munich, Germany
         type:PostalAddress
      name:Teilgemeinschaftspraxis Molekularpathologie Südbayern
      address:
         name:Teilgemeinschaftspraxis Molekularpathologie Südbayern, Munich, Germany
         type:PostalAddress
      name:Technische Universität München
      address:
         name:Institute of Pathology, Technische Universität München, Munich, Germany
         type:PostalAddress
      name:University of Bern
      address:
         name:Institute of Pathology, University of Bern, Bern, Switzerland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Julia Slotta-Huspenina
      affiliation:
            name:Technische Universität München
            address:
               name:Institute of Pathology, Technische Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Enken Drecoll
      affiliation:
            name:Technische Universität München
            address:
               name:Institute of Pathology, Technische Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Marcus Feith
      affiliation:
            name:Klinikum Rechts der Isar, Technische Universität München
            address:
               name:Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Daniel Habermehl
      affiliation:
            name:Klinikum Rechts der Isar, Technische Universität München
            address:
               name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Stephanie Combs
      affiliation:
            name:Klinikum Rechts der Isar, Technische Universität München
            address:
               name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Wilko Weichert
      affiliation:
            name:Technische Universität München
            address:
               name:Institute of Pathology, Technische Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Marcus Bettstetter
      affiliation:
            name:Teilgemeinschaftspraxis Molekularpathologie Südbayern
            address:
               name:Teilgemeinschaftspraxis Molekularpathologie Südbayern, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Karen Becker
      affiliation:
            name:Technische Universität München
            address:
               name:Institute of Pathology, Technische Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Rupert Langer
      url:http://orcid.org/0000-0001-9491-3609
      affiliation:
            name:University of Bern
            address:
               name:Institute of Pathology, University of Bern, Bern, Switzerland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute of Pathology, Technische Universität München, Munich, Germany
      name:Institute of Pathology, Technische Universität München, Munich, Germany
      name:Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
      name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
      name:Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
      name:Institute of Pathology, Technische Universität München, Munich, Germany
      name:Teilgemeinschaftspraxis Molekularpathologie Südbayern, Munich, Germany
      name:Institute of Pathology, Technische Universität München, Munich, Germany
      name:Institute of Pathology, University of Bern, Bern, Switzerland

External Links {🔗}(205)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.46s.

LINK . SPRINGER . COM {}